Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane on RIPC Cardioprotection
NCT02932722Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol and sevoflurane in myocardial infarction (MI) (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: Infarct size of the rat heart at 1 day. Started Feb 2017; status: completed.
02
Drugs
propofolsevoflurane
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02932722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02932722.